3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
45
Recruiting
23
Active not recruiting
23
Unknown
12
Terminated
8
Not yet recruiting
6
Withdrawn
2
Suspended
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Carcinoma In Situ
1
Interventions
Paclitaxel
3
Surgical Procedures, Operative
2
Radiotherapy
2
Oxaliplatin
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
Doxorubicin
2
Cyclophosphamide
2
titanium silicide
1
sargramostim
1
exemestane
1
eribulin
1
cemiplimab
1
Vincristine
1
Taxes
1
Tamoxifen
1
Surveys and Questionnaires
1
Specimen Handling
1
S 1 (combination)
1
Rituximab
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Prednisone
1
Prednisolone
1
Passive Cutaneous Anaphylaxis
1
Neoadjuvant Therapy
1
Morphine
1
Methylprednisolone
1
Methotrexate
1
Methods
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Suspended
×
Letrozole
×
Clear all
NCT06671912
2026-05-08
LoTam
Alliance for Clinical Trials in Oncology
Phase 3
Suspended
1,156 enrolled